PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
BBI vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

BBI vs. XLV

Last updated May 22, 2025

Compare and contrast key facts about Brickell Biotech, Inc. (BBI) and Health Care Select Sector SPDR Fund (XLV).

XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBI or XLV.

Correlation

The correlation between BBI and XLV is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

BBI vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Brickell Biotech, Inc. (BBI) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

BBI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

XLV

YTD

-3.98%

1M

-0.75%

6M

-7.13%

1Y

-8.58%

3Y*

2.09%

5Y*

7.40%

10Y*

7.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Brickell Biotech, Inc.

Health Care Select Sector SPDR Fund

Risk-Adjusted Performance

BBI vs. XLV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BBI
The Risk-Adjusted Performance Rank of BBI is 6767
Overall Rank
The Sharpe Ratio Rank of BBI is 5959
Sharpe Ratio Rank
The Sortino Ratio Rank of BBI is 7272
Sortino Ratio Rank
The Omega Ratio Rank of BBI is 7272
Omega Ratio Rank
The Calmar Ratio Rank of BBI is 6363
Calmar Ratio Rank
The Martin Ratio Rank of BBI is 6767
Martin Ratio Rank
XLV
The Risk-Adjusted Performance Rank of XLV is 33
Overall Rank
The Sharpe Ratio Rank of XLV is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of XLV is 33
Sortino Ratio Rank
The Omega Ratio Rank of XLV is 33
Omega Ratio Rank
The Calmar Ratio Rank of XLV is 22
Calmar Ratio Rank
The Martin Ratio Rank of XLV is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BBI vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Brickell Biotech, Inc. (BBI) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data

Loading data...

Dividends

BBI vs. XLV - Dividend Comparison

BBI has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.78%.

TTM20242023202220212020201920182017201620152014
BBI
Brickell Biotech, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund		1.78%1.67%1.59%1.47%1.33%1.49%2.17%1.57%1.47%1.60%1.43%1.35%

Drawdowns

BBI vs. XLV - Drawdown Comparison

Loading data...

Volatility

BBI vs. XLV - Volatility Comparison

Loading data...